Shaoqing Ju

Prof. Shaoqing Ju

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
TWTianyi Wang
Tianyi Wang
SKShan Kong
Shan Kong
MTMei Tao
Mei Tao
SJShaoqing Ju
Shaoqing Ju
N6-methyladenosine (m6A) is considered the most common, abundant, and conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA). m6A is installed by m6A methyltransferases (METTL3/14, WTAP, RBM15/15B, VIRMA and ZC3H13, termed “writers”), removed by demethylases (FTO, ALKBH5, and ALKBH3, termed “erasers”), and recognized by m6A-binding proteins (YTHDC1/2, YTHDF1/2/3, IGF2BP1/2/3, HNRNP, and eIF3, termed “readers”). Accumulating evidence suggests that m6A RNA methylation greatly impacts RNA metabolism and is involved in the pathogenesis of many kinds of diseases, including cancers. In this review, we focus on the physiological functions of m6A modification and its related regulators, as well as on the potential biological roles of these elements in human tumors.

5 August 2020 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SMShuo Ma
Shuo Ma
SKShan Kong
Shan Kong
FWFeng Wang
Feng Wang
SJShaoqing Ju
Shaoqing Ju
Targeted treatment, which can specifically kill tumour cells without affecting normal cells, is a new approach for tumour therapy. However, tumour cells tend to acquire resistance to targeted drugs during treatment. Circular RNAs (circRNAs) are single-stranded RNA molecules with unique structures and important functions. With the development of RNA sequencing technology, circRNAs have been found to be widespread in tumour-resistant cells and to play important regulatory roles. In this review, we present the latest advances in circRNA research and summarize the various mechanisms underlying their regulation. Moreover, we review the role of circRNAs in the chemotherapeutic resistance of tumours and explore the clinical value of circRNA regulation in treating tumour resistance.

1 July 2020 in Cancer Letters
Verified
Journal Article
Closed access
SKShan Kong
Shan Kong
MTMei Tao
Mei Tao
XSXianjuan Shen
Xianjuan Shen
SJShaoqing Ju
Shaoqing Ju

16 June 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CJChunjing Jin
Chunjing Jin
WSWei Shi
Wei Shi
FWFeng Wang
Feng Wang
XSXianjuan Shen
Xianjuan Shen
JQJing Qi
Jing Qi
SJShaoqing Ju
Shaoqing Ju
Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer

2 June 2020 in Molecular Cancer
Verified
Journal Article
Open access
WFWei Feng
Wei Feng
WZWei Zong
Wei Zong
FWFeng Wang
Feng Wang
SJShaoqing Ju
Shaoqing Ju
In recent years, the prevalence and spread of coronavirus has had a huge impact on global public health. Due to the incomplete understanding of the pathogenic mechanism of the virus, it is difficult for humans to fight against the virus quickly and effectively once the outbreak occurs. In early 2020, a novel coronavirus was discovered in Wuhan, China. Soon after, similar cases were found in other countries around the world, and the number of infected people increased rapidly. So far, the global cumulative number of infected people has exceeded 3 million, and more than 200,000 people have died, which has had a huge impact on global human health and economic development. Every outbreak of disease makes a deep impression on mankind. Herein, we summarize the virology, epidemiology, clinical manifestations, diagnosis, treatment and prevention of SARS-CoV-2, and hope that countries can control the outbreak as soon as possible to minimize the loss.

26 August 2021 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
MTMei Tao
Mei Tao
MZMing Zheng
Ming Zheng
YXYanhua Xu
Yanhua Xu
SMShuo Ma
Shuo Ma
WZWeiwei Zhang
Weiwei Zhang
SJShaoqing Ju
Shaoqing Ju
Circular RNAs (circRNAs), a novel type of non-coding RNAs (ncRNAs), have a covalently closed circular structure resulting from pre-mRNA back splicing via spliceosome and ribozymes. They can be classified differently in accordance with different criteria. As circRNAs are abundant, conserved, and stable, they can be used as diagnostic markers in various diseases and targets to develop new therapies. There are various functions of circRNAs, including sponge for miR/proteins, role of scaffolds, templates for translation, and regulators of mRNA translation and stability. Without m7G cap and poly-A tail, circRNAs can still be degraded in several ways, including RNase L, Ago-dependent, and Ago-independent degradation. Increasing evidence indicates that circRNAs can be modified by N-6 methylation (m6A) in many aspects such as biogenesis, nuclear export, translation, and degradation. In addition, they have been proved to play a regulatory role in the progression of various cancers. Recently, methods of detecting circRNAs with high sensitivity and specificity have also been reported. This review presents a detailed overview of circRNAs regarding biogenesis, biomarker, functions, degradation, and dynamic modification as well as their regulatory roles in various cancers. It’s particularly summarized in detail in the biogenesis of circRNAs, regulation of circRNAs by m6A modification and mechanisms by which circRNAs affect tumor progression respectively. Moreover, existing circRNA detection methods and their characteristics are also mentioned.